{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:58:51Z","timestamp":1791773931227,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.tox.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T01:42:43Z","timestamp":1363398163000},"page":"11-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Toxicity of thienopyridines on human neutrophil granulocytes and lymphocytes"],"prefix":"10.1016","volume":"308","author":[{"given":"Swarna","family":"Maseneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Brecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kr\u00e4henb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2013.03.002_bib0005","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1345\/aph.1E119","article-title":"Neutropenia due to clopidogrel in a patient with end-stage renal disease","volume":"38","author":"Akcay","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tox.2013.03.002_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archinte.161.1.125","article-title":"Febrile pancytopenia associated with clopidogrel","volume":"161","author":"Andres","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.mjt.0000212708.81034.22","article-title":"Hematologic adverse effects of clopidogrel","volume":"14","author":"Balamuthusamy","year":"2007","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.tox.2013.03.002_bib0020","first-page":"641","article-title":"Leukopenia due to ticlopidine in a patient with chronic renal failure","volume":"69","author":"Bedani","year":"1984","journal-title":"Haematologica"},{"key":"10.1016\/j.tox.2013.03.002_bib0025","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/FPC.0b013e32810f2e58","article-title":"Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues","volume":"17","author":"Bieche","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"issue":"Suppl. 2","key":"10.1016\/j.tox.2013.03.002_bib0035","first-page":"25","article-title":"Pharmacokinetics of clopidogrel","volume":"25","author":"Caplain","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.tox.2013.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"CAPRIE-Steering-Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2013.03.002_bib0045","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.2174\/092986709789378206","article-title":"Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein","volume":"16","author":"Caroppi","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2013.03.002_bib0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/dmd.31.1.53","article-title":"The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin","volume":"31","author":"Clarke","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2013.03.002_bib0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0091270009343005","article-title":"Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans","volume":"50","author":"Farid","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2013.03.002_bib0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1177\/106002809402801203","article-title":"Delayed neutropenia with ticlopidine","volume":"28","author":"Farver","year":"1994","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tox.2013.03.002_bib0065","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.ATV.19.8.2007","article-title":"Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel","volume":"19","author":"Geiger","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tox.2013.03.002_bib0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Gent","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2013.03.002_bib0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000206335","article-title":"Anaemia and agranulocytosis associated with ticlopidine therapy","volume":"73","author":"Guerciolini","year":"1985","journal-title":"Acta Haematol."},{"key":"10.1016\/j.tox.2013.03.002_bib0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/pgmj.74.868.126","article-title":"Ticlopidine-induced severe neutropenia","volume":"74","author":"Gur","year":"1998","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.tox.2013.03.002_bib0085","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group","volume":"321","author":"Hass","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mito.2011.01.010","article-title":"The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis","volume":"11","author":"Huttemann","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tox.2013.03.002_bib0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20634","article-title":"Mechanisms of benzarone and benzbromarone-induced hepatic toxicity","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2013.03.002_bib0105","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00018-006-6235-z","article-title":"Toxicity of statins on rat skeletal muscle mitochondria","volume":"63","author":"Kaufmann","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tox.2013.03.002_bib0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2013.03.002_bib0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1182\/blood.V80.1.225.225","article-title":"Effects of gamma-interferon on human neutrophils: protection from deterioration on storage","volume":"80","author":"Klebanoff","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.tox.2013.03.002_bib0120","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/00498259209053121","article-title":"Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effects on antipyrine pharmacokinetics","volume":"22","author":"Knudsen","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2013.03.002_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0300-2977(98)00127-2","article-title":"Ticlopidine-induced thrombocytopenia","volume":"54","author":"Koornstra","year":"1999","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0130","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/106002809302700910","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine","volume":"27","author":"Kovacs","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tox.2013.03.002_bib0135","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuint.2012.03.007","article-title":"Fluazinam targets mitochondrial complex I to induce reactive oxygen species-dependent cytotoxicity in SH-SY5Y cells","volume":"60","author":"Lee","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tox.2013.03.002_bib0140","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0090-9556(24)15339-1","article-title":"Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis","volume":"28","author":"Liu","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2013.03.002_bib0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2012.05.017","article-title":"Toxicity of clopidogrel and ticlopidine on human myeloid progenitor cells: importance of metabolites","volume":"299","author":"Maseneni","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2013.03.002_bib0150","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archinte.160.9.1370","article-title":"Hemolytic uremic syndrome associated with clopidogrel: a case report","volume":"160","author":"Moy","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00000441-200109000-00013","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel administration: case report and brief review","volume":"322","author":"Nara","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.tox.2013.03.002_bib0160","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3109\/00498250903191427","article-title":"Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel","volume":"39","author":"Nishiya","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2013.03.002_bib0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF01940544","article-title":"Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds","volume":"44","author":"Pincemail","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/j.tox.2013.03.002_bib0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbabio.2011.02.012","article-title":"Shedding light on the mitochondrial permeability transition","volume":"1807","author":"Ricchelli","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tox.2013.03.002_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/jpet.103.056127","article-title":"Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine","volume":"308","author":"Richter","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2013.03.002_bib0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/bbrc.2001.4816","article-title":"P2y(12), a new platelet ADP receptor, target of clopidogrel","volume":"283","author":"Savi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tox.2013.03.002_bib0185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.tox.2013.03.002_bib0190","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0195","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"Sorensen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2013.03.002_bib0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajh.10150","article-title":"Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases","volume":"71","author":"Symeonidis","year":"2002","journal-title":"Am. J. Hematol."},{"issue":"138\u2013139","key":"10.1016\/j.tox.2013.03.002_bib0205","first-page":"A110","article-title":"Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting","volume":"83","author":"Szto","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tox.2013.03.002_bib0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1160\/TH04-02-0105","article-title":"Pharmacokinetics of clopidogrel after administration of a high loading dose","volume":"92","author":"Taubert","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.tox.2013.03.002_bib0215","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(00)04015-0","article-title":"Fatal aplastic anaemia associated with clopidogrel","volume":"357","author":"Trivier","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2013.03.002_bib0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5152\/akd.2010.075","article-title":"Nonfatal aplastic anemia associated with clopidogrel","volume":"10","author":"Uz","year":"2010","journal-title":"Anadolu Kardiyol. Derg."},{"key":"10.1016\/j.tox.2013.03.002_bib0225","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1124\/jpet.106.108993","article-title":"Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives","volume":"319","author":"Waldhauser","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2013.03.002_bib0230","first-page":"307","article-title":"Assaying cytochrome C translocation during apoptosis","volume":"284","author":"Waterhouse","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tox.2013.03.002_bib0235","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0240","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Clopidogrel in unstable angina to prevent recurrent events trial I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2013.03.002_bib0245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1476-5381.2010.00881.x","article-title":"Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro","volume":"161","author":"Zahno","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2013.03.002_bib0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cvr\/cvp151","article-title":"Regulation and pharmacology of the mitochondrial permeability transition pore","volume":"83","author":"Zorov","year":"2009","journal-title":"Cardiovasc. Res."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X13000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X13000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:23:08Z","timestamp":1759533788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X13000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":50,"alternative-id":["S0300483X13000644"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2013.03.002","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity of thienopyridines on human neutrophil granulocytes and lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}